[Nutrition, lifestyle, physical activity, and supportive care during chemotherapeutic treatment]
Standard
[Nutrition, lifestyle, physical activity, and supportive care during chemotherapeutic treatment]. / Lümmen, G; Jäger, T; Sommer, Frank; Ebert, T; Schmitz-Draeger, B.
In: UROLOGE, Vol. 45, No. 5, 5, 2006, p. 555-558, 560-565.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - [Nutrition, lifestyle, physical activity, and supportive care during chemotherapeutic treatment]
AU - Lümmen, G
AU - Jäger, T
AU - Sommer, Frank
AU - Ebert, T
AU - Schmitz-Draeger, B
PY - 2006
Y1 - 2006
N2 - With improvements in cancer survival rates, more patients with cancer are living longer and the influence of nutrition, lifestyle, physical activity as well as supportive care during and after chemotherapy is of increasing interest. In several malignancies smoking cessation increases cancer survival. Similar effects are expected by healthy nutrition. Regular physical activity of cancer patients reduces drug interactions of chemotherapy, decreases the number of comorbid conditions, and helps patients maintain independence as long as possible. For supportive care during chemotherapy the 5-HT3 receptor antagonists are more effective for the prevention of chemotherapy-induced nausea and vomiting. There are several colony-stimulating factors (e.g. GCSF, erythropoietin) for hematopoietic recovery post-chemotherapy. Altogether supportive care of chemotherapy reduces toxicity and increases efficacy.
AB - With improvements in cancer survival rates, more patients with cancer are living longer and the influence of nutrition, lifestyle, physical activity as well as supportive care during and after chemotherapy is of increasing interest. In several malignancies smoking cessation increases cancer survival. Similar effects are expected by healthy nutrition. Regular physical activity of cancer patients reduces drug interactions of chemotherapy, decreases the number of comorbid conditions, and helps patients maintain independence as long as possible. For supportive care during chemotherapy the 5-HT3 receptor antagonists are more effective for the prevention of chemotherapy-induced nausea and vomiting. There are several colony-stimulating factors (e.g. GCSF, erythropoietin) for hematopoietic recovery post-chemotherapy. Altogether supportive care of chemotherapy reduces toxicity and increases efficacy.
M3 - SCORING: Zeitschriftenaufsatz
VL - 45
SP - 555-558, 560-565
JO - UROLOGE
JF - UROLOGE
SN - 0340-2592
IS - 5
M1 - 5
ER -
